Bioqube Ventures is a specialist life sciences investment firm. We source, finance and develop innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.

Bioqube Ventures launched in 2020 its first independent fund “Bioqube Factory Fund I”.

… An early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.

… A fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. 

… A hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.

Bioqube Ventures

Fellowship opportunity! Do you have a scientific background, are you passionate about developing therapeutics and eager to learn more about what makes venture capital tick in biotech? Then this 6-month Fellowship program at Bioqube might be the right fit for you! Find out more in the description below ⤵️ #vc #biotech #fellowship

Exciting update from our portfolio company @Bicara Therapeutics at @ESMO !

Welcome Krishna Polu ! What a great addition to our Bioqube Ventures team! Proud to be part of this family!

Exciting update from Bioqube portfolio company Bicara Therapeutics, congratulations to the team on unveiling their manuscript. Read all about it below. #aacr23 #BFFI
https://lnkd.in/eMAwSuya

Bioqube Ventures is pleased to welcome Bicara Therapeutics to our portfolio, a clinical-stage biotech advancing its lead program BCA101 and its pipeline of investigational candidates to treat solid tumor cancers.

https://lnkd.in/efJAtW9Q

Rappta Therapeutics is a competitor of Anavo Therapeutics in the field of allosteric modulators for phosphatases.

Rappta Therapeutics

Anavo Therapeutics is a biotechnology company focused on the development of allosteric modulators for phosphatases, aiming to create a pipeline of novel therapeutics for various diseases.

Anavo Therapeutics

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

news_advanced

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	May 9, 2024 6:39 AM	047ca67f
public peers	general	May 9, 2024 6:39 AM	677ba0c2
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 9, 2024 6:39 AM	f06ecb10
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general	May 9, 2024 6:39 AM	e9a9ea55
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
swot analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
customer profile	customers

COM:BIOQUBEVENTURES

Anavo Therapeutics